Cardiovascular disease in women

Circulation

Volumn 88, Issue 4, 1993, Pages 1999-2009

  Eaker, Elaine D ^a   Chesebro, James H ^a   Sacks, Frank M ^a   Wenger, Nanette K ^a   Whisnant, Jack P ^a   Winston, Mary ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DISABILITY; FEMALE; HEALTH EDUCATION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; ORAL CONTRACEPTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; INCIDENCE; MENOPAUSE; MIDDLE AGE; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 0027449423     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.4.1999     Document Type: Article

References (141)

1. Kannel WB, Abbott RD. Incidence and prognosis of myocardial infarction in women: the Framingham Study. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987.
2. Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, Rifkind BM. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993;269:3009-3014.
3. Soldo BJ, Manton KG. Health status and service needs of the oldest old: current patterns and future trends. Milbank Mem Fund Q Health Soc. 1985;63:286-319.
4. Pinsky JL, Jette AM, Branch LG, Kannel WB, Feinleib M. The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health, 1990;80:1363-1367.
5. 1993 Heart and Stroke Facts Statistics. Dallas, Tex: American Heart Association; 1992.
6. Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA. Coronary artery disease in women. Am J Cardiol. 1988;61: 641-644.
7. National Heart, Lung, and Blood Institute. Expenditures in 1980 Health Care Financing Administration Review. 1984;5.
8. US Senate Special Committee on Aging. Aging America: Trends and Projections. Washington, DC: US Dept of Health and Human Services; 1988.
9. Thorn TJ. Cardiovascular disease mortality among United States women. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987.
10. Eaker ED, Castelli WP. Coronary heart disease and its risk factors among women in the Framingham Study. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987.
11. Higgins M, Keller JB, Ostrander LD. Risk factors for coronary heart disease in women: Tecumseh Community Health Study, 1959 to 1980. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:83-89.
12. Keil JE, Gazes PC, Loadholt CB, et al. Coronary heart disease and its predictors among women in Charleston, South Carolina. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:90-98.
13. Wingard DL, Cohn BA. Coronary heart disease mortality among women in Alameda County, 1965 to 1973. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:99-105.
14. Bush TL, Criqui MH, Cowan LD, et al. Cardiovascular disease mortality in women: results from the Lipid Research Clinics Follow-up Study. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:106-111.
15. Stampfer MJ, Colditz GA, Willett WC, et al. Coronary heart disease risk factors in women: the Nurses' Health Study experience. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:112-116.
16. Barren-Connor E, Khaw KT, Wingard DL. A ten-year prospective study of coronary heart disease mortality among Rancho Bernardo women. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:117-121.
17. Barren-Connor EL. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med. 1985;103:1010-1019.
18. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;678:968-977.
19. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity: a reassessment. JAMA. 1987;257:353-358.
20. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA. 1989;262: 2395-2401.
21. Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;266:521-527.
22. Centers for Disease Control. MMWR CDC Surveill Summ. 1991; 40:1-24.
23. Coronary heart disease attributable to sedentary lifestyle-selected states, 1988. Morb Mortal Wkly Rep. 1990;39:541-544.
24. Orencia A, Bailey K, Yawn BP, Kottke TE. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/ sudden unexpected death. JAMA. 1993;269:2392-2402.
25. Davis KB. Coronary artery bypass graft surgery in women. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:247-250.
26. Kennedy JW, Killip T, Fisher LD, Alderman EL, Gillespie MJ, Mock MB. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979: the Coronary Artery Surgery study. Circulation. 1982;66(pt 2):III-16-III-23.
27. Waters DD, Halphen C, Theroux P, David PR, Mizgala HF. Coronary artery disease in young women: clinical and angiographic features and correlation with risk factors. Am J Cardiol. 1978;42:41-47.
28. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study: prognosis and survival. Am J Cardiol. 1972; 29:154-163.
29. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383-390.
30. Tofler GH, Stone PH, Muller JE, Willich SN, Davis VG, Poole WK, Strauss HW, Willerson JT, Jaffe AS, Robertson T, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987;9:473-482.
31. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation. 1991;83: 484-491.
32. Hendel RC. Myocardial infarction in women. Cardiology. 1990; 77(suppl 2):41-57.
33. Dustan HP. Coronary artery disease in women. Can J Cardiol. 1990;6(suppl B):19B-21B.
34. Marmor A, Geltman EM, Schechtman K, Sobel BE, Roberts R. Recurrent myocardial infarction: clinical predictors and prognostic implications. Circulation. 1982;66:415-421.
35. Fisher LD, Kennedy JW, Davis KB, Maynard C, Fritz JK, Kaiser G, Myers WO. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg. 1982;84: 334-341.
36. Tofler GH, Stone PH, Muller JE, et al. Clinical manifestations of coronary heart disease in women. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:215-221.
37. Gruppo Italiano per lo Studio della Streptochinasi nell 'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
38. Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after acute myocardial infarction. N Engl J Med. 1985;313:1055-1058.
39. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS -2. J Am Coll Cardiol. 1988;12(suppl A):3A-13A.
40. Hutter AM. Coronary artery disease in women: medical management. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987:229-232.
41. Moss AJ, Carleen E, and Multicenter Postinfarction Research Group. Gender differences in the mortality risk associated with ventricular arrhythmias after myocardial infarction. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1987: 204-214.
42. Loop FD, Golding LR, MacMillan JP, Cosgrove DM, Lytle BW, Sheldon WC. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol. 1983;1(pt 1):383-390.
43. Gardner TJ, Horneffer PJ, Gott VL, Watkins L Jr, Baumgartner WA, Borkon AM, Reitz BA. Coronary artery bypass grafting in women: a ten-year perspective. Ann Surg. 1985;201:780-784.
44. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-225.
45. Khan SS, Nessim S, Gray R, Czer LS, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med. 1990;112:561-567.
46. Stanton BA, Zyzanski SJ, Jenkins CD, et al. Recovery after major heart surgery: medical, psychological and work outcomes. In: Becker R, ed. Psychopathological and Neurological Dysfunctions Following Open-Heart Surgery. New York, NY: Springer -Verlag; 1982:217-226.
47. Stanton BA, Jenkins CD, Denlinger P, Savageau JA, Weintraub RM, Goldstein RL. Predictors of employment status after cardiac surgery. JAMA. 1983;249:907-911.
48. Cowley MJ, Mullin SM, Kelsey SF, Kent KM, Gruentzig AR, Detre KM, Passamani ER. Sex differences in early and long -term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation. 1985;71:90-97.
49. Holmes DR Jr, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, Williams DO, Cowley MJ, Faxon DP, Kent KM, Bentivoglio LG, Detre K, and the coinvestigators of the National Heart, Lung, and Blood Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1988;12:1149-1155.
50. Savage MP, Goldberg S, Hirshfeld JW, Bass TA, MacDonald RG, Margolis JR, Taussig AS, Vetrovec G, Whirworth HB, Zalewski A, Hill JA, Cowley M, Jugo R, Pepine CJ, for the M-Heart Investigators. J Am Coll Cardiol. 1991;17:22-28.
51. Oldridge NB, LaSalle D, Jones NL. Exercise rehabilitation of female patients with coronary heart disease. Am Heart J. 1980; 100:755-757.
52. Cannistra LB, Balady GJ, O'Malley CJ, Weiner DA, Ryan TJ. Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol. 1992;69:1274-1279.
53. Boogaard MAK, Briody MD. Comparison of the rehabilitation of men and women in post-myocardial infarction. J Cardiopulmonary Rehabil. 1985;5:379.
54. Cooper R, Sempos C, Hsieh SC, Kovar MG. Slowdown in the decline of stroke mortality in the United States, 1978-1986. Stroke. 1990;21:1274-1279.
55. Whelton PK, Klag MJ. Recent trends in the epidemiology of stroke: what accounts for the persistent decline in stroke mortality in Western nations? Curr Opin Cardiol. 1987;2:741-747.
56. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke. 1990;21:989-992.
57. Anderson GL, Whisnant JP. A comparison of trends in mortality from stroke in the United States and Rochester, Minnesota. Stroke. 1982;13:804-809.
58. al-Roomi KA, Dobson AJ, Hall E, Heller RF, Magnus P. Declining mortality from ischemic heart disease and cerebrovascular disease in Australia. Am J Epidemiol. 1989;129: 503-510.
59. Gillum RF. Stroke in blacks. Stroke. 1988;19:1-9.
60. Corwin LE, Wolf PA, Kannel WB, McNamara PM. Accuracy of death certification of stroke: the Framingham Study. Stroke. 1982; 13:818-821.
61. Iso H, Jacobs DR Jr, Goldman L. Accuracy of death certificate diagnosis of intracranial hemorrhage and nonhemorrhagic stroke: the Minnesota Heart Survey. Am J Epidemiol. 1990;132:993-998.
62. Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20:577-582.
63. Terent A. Increasing incidence of stroke among Swedish women. Stroke. 1988;19:598-603.
64. Wiebers DO, Whisnant JP. The incidence of stroke among pregnant women in Rochester, Minn, 1955 through 1979. JAMA. 1985;254:3055-3057.
65. Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48:194-198.
66. Dennis MS, Bamford JM, Sandercock PAG, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke. 1989;20:333-339.
67. Whisnant JP, Melton LJ III, Davis PH, O'Fallon WM, Nishimaru K, Schoenberg BS. Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke. J Clin Epidemiol. 1990; 43:791-797.
68. Drury I, Whisnant JP, Garraway WM. Primary intracerebral hemorrhage: impact of CT on incidence. Neurology. 1984;34: 653-657.
69. Ingall TJ, Whisnant JP, Wiebers DO, O'Fallon WM. Has there been a decline in subarachnoid hemorrhage mortality? Stroke. 1989;20:718-724.
70. Davis PH, Dambrosia JM, Schoenberg BS, Schoenberg DG, Pritchard DA, Lilienfeld AM, Whisnant JP. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann Neurol. 1987;22:319-327.
71. Thompson SG, Greenberg G, Meade TW. Risk factors for stroke and myocardial infarction in women in the United Kingdom as assessed in general practice: a case-control study. Br Heart J. 1989;61:403-409.
72. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
73. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ. 1988; 297:519-522.
74. Finucane F, Madans J, Bush T, Wolf P, Kleinmann J. Decreased risk of stroke among post-menopausal hormone users: results from a natural cohort. Arch Intern Med. In press.
75. Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol. 1979;5:367-373.
76. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986;17: 1078-1083.
77. Longstreth WT Jr, Koepsell TD, Yerby MS, van Belle G. Risk factors for subarachnoid hemorrhage. Stroke. 1985;16:377-385.
78. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke. 1986;17:831-835.
79. Phillips LH II, Whisnant JP, O'Fallon WM, Sundt TM Jr. The unchanging pattern of subarachnoid hemorrhage in a community. Neurology. 1980;30:1034-1040.
80. Phillips SJ, Whisnant JP, O'Fallon WM, Hickman RD. A community blood pressure survey: Rochester, Minnesota, 1986. Mayo Clin Proc. 1988;63:691-699.
81. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc. 1990;65:344-359.
82. Centers for Disease Control. Tobacco use by adults: United States, 1987. JAMA. 1989;262:2364, 2369.
83. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the United States: projections to the year 2000. JAMA. 1989;261:61-65.
84. Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol. 1991;30:511-518.
85. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, III: reduction in stroke incidence among persons with high blood pressure. JAMA. 1982;247:633-638.
86. Garraway WM, Whisnant JP. The changing pattern of hypertension and the declining incidence of stroke. JAMA. 1987;258: 214-217.
87. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
88. Whisnant JP, Homer D, Ingall TJ, Baker HL Jr, O'Fallon WM, Wievers DO. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke. 1990;21:707-714.
89. Colditz GA, Bonita R, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH. Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937-941.
90. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025-1029.
91. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J [Clin Res]. 1988;296:320-331.
92. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
93. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
94. Gillum RF. Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J. 1990; 120(pt 1):1414-1418.
95. Framingham Heart Study Monograph No. 34. Bethesda, Md; US Dept of Health and Human Services.
96. Newman AB, Sutton-Tyrrell K, Rutan GH, Locher J, Kuller LH. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol. 1991;44:15-20.
97. Abbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med. 1990;88:376-381.
98. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med. 1981;305:612-618.
99. Sartwell PE, Stolley PD. Oral contraceptives and vascular disease. Epidemiol Rev. 1982;4:95-109.
100. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 1985;253:2965-2969.
101. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992;136:408-416.
102. Mant D, Villard-Mackintosh L, Vessey MP, Yeates D. Myocardial infarction and angina pectoris in young women. J Epidemiol Community Health. 1987;41:215-219.
103. La Vecchia C, Franceschi S, Decarli A, Pampallona S, Tognoni G. Risk factors for myocardial infarction in young women. Am J Epidemiol. 1987;125:832-843.
104. Hirvonen P, ed. Pathogenesis, Prevention, and Treatment of Coronary Heart Disease: Proceedings of the Helsinki Heart Symposium, Hanasaari, Finland, June 1-2, 1984. Stockholm, Sweden: Almqvist and Wiksell Periodical Co; 1985.
105. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study. Am J Obstet Gynecol. 1990;163(pt 2):285-291.
106. Kissebah AH, Harrigan P, Wynn V. Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res. 1973;5:184-190.
107. Wahl P, Waiden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B. Effect of estrogen/progestin potency on lipid/ lipoprotein cholesterol. N Engl J Med. 1983;308:862-867.
108. La Rosa JC. The varying effects of progestins on lipid levels and cardiovascular disease. Am J Obstet Gynecol. 1988;158(pt 2): 1621-1629.
109. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323:1375-1381.
110. Patsch W, Brown SA, Gotto AM Jr, Young RL. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins. Am J Obstet Gynecol. 1989;161:1396-1401.
111. Notelovitz M, Feldman EB, Gillespy M, Gudat J. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial. Am J Obstet Gynecol. 1989;160(pt 2): 1269-1280.
112. Walsh BW, Sacks FM. Effects of low-dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest. 1993;91:2126-2132.
113. Boonsiri B, Kolkijkovinda S, Chutivongse S, Crona N, Medberg M, Gundersen G, Samsioe G, Garza-Flores J, Valles de Bourges V, Juarez-Ayala J, et al. A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users: World Health Organization Task Force on Oral Contraceptives. Contaception. 1988;38:605-629.
114. Kjos SL, Shoupe D, Douyan S, Friedman RL, Bernstein GS, Mestman JH, Mishell DR Jr. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. Am J Obstet Gynecol. 1990;163(pt 1):1822-1827.
115. Burkman RT, Zacur HA, Kimball AW, Kwiterovich P, Bell WR. Oral contraceptives and lipids and lipoproteins, part I: variations in mean levels by oral contraceptive type. Contraception. 1989;40: 553-561.
116. Harvengt C, Desager JP, Gaspard U, Lepot M. Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins. Contraception. 1988;37:565-575.
117. Kafrissen ME. A norgestimate-containing oral contraceptive: review of clinical studies. Am J Clin Nutr. 1992;167:1196-1202
118. Gevers Leuven JA, Dersjant-Roorda MD, Helmerhorst FM, de Boer R, Neymeyer-Leloux A, Havekes L. Estrogenic effect of gestodene- or desogestrel-containng oral contraceptives on lipoprotein metabolism. Am J Obstet Gynecol. 1990;163(1 pt 2): 358-362.
119. Weiss NS Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980;303: 1195-1198.
120. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
121. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
122. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991; 151:75-78.
123. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med. 1990;150:2557-2562.
124. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
125. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
126. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL. Biologic effects of transdermal estradiol. N Engl J Med. 1986;314: 1615-1620.
127. Sacks FM, Walsh BW. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci. 1990;592:272-285.
128. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab. 1983;57:262-267.
129. Barrett-Connor E, Laakso M. Ischemic heart disease risk in postmenopausal women: effects of estrogen use on glucose and insulin levels. Arteriosclerosis. 1990;10:531-534.
130. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990; 81:1680-1687.
131. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 1987;76:753-758.
132. Hough JL, Zilversmit DB. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986;6:57-63.
133. Adams MR, Clarkson TB, Koritnik DR, Nash HA. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril. 1987;47:1010-1018.
134. Wagner JD, St Clair RW, Schwenke DC, Shivery CA, Adams MR, Clarkson TB. Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys: effects of estrogen and progesterone replacement therapy. Arterioscler Thromb. 1992;12:717-726.
135. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low-density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
136. Brinton LA. Menopause and the risk of breast cancer. Ann N Y Acad Sci. 1990;592:357-362.
137. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med. 1991;151:67-72.
138. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321:293-297.
139. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark, Int J Cancer. 1988;42:832-838.
140. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991;265:1985-1990.
141. Wenger NK, Speroff L, Packard B, eds. Cardiovascular Health and Disease in Women: Proceedings of a National Heart, Lung, and Blood Institute Conference, January 22-24, 1992. Greenwich, Conn; Le Jacq Communications. In press.